Neurotez Inc.
Neurotez Inc. is developing a drug to treat Leptin deficiency and cognitive decline in Alzheimer’s disease patients.
751 days open
START
August 31, 2022
Discover our exclusive features for registered users
Understand when and how people have invested in a campaign with our hourly commitments and investor data.
Benefit from AI-powered company descriptions and other important information.
Access financial statements from various sources in one convenient location.
No subscription required - Wixdom is and will remain free to use! Register now to access our industry-leading crowdfunding data.
Sign up for free